Mechanism of action of the diazabicyclononanone-type κ-agonists

Journal of Medicinal Chemistry

Volumn 46, Issue 8, 2003, Pages 1383-1389

  Holzgrabe, Ulrike ^a   Brandt, Wolfgang ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b LEIBNIZ INSTITUTE OF PLANT BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DI 2 PYRIDYL 3,7 DIMETHYL 3,7 DIAZABICYCLO[3.3.1]NONAN 9 ONE 1,5 DIESTER; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ACETAMIDE DERIVATIVE; ASIMADOLINE; CARBONYL DERIVATIVE; DIAZABICYCLONONANONE; ENADOLINE; GLUTAMIC ACID; HZ 2; KAPPA OPIATE RECEPTOR AGONIST; KETAZOCINE; LYSINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHEMICAL BOND; DRUG ACTIVITY; DRUG BINDING SITE; DRUG CONFORMATION; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, OPIOID, KAPPA;

EID: 0037431393     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0210360     Document Type: Article

References (37)

1. Alexander, S. P. H.; Mathie, A.; Peters J. A. 2001 Nomenclature Supplement. Trends Pharmacol. Sci. 2001.
2. Barber, A.; Gottschlich, R. Novel development with selective, nonpeptidic kappa-opioid receptor agonists. Exp. Opin. Invest. Drugs 1997, 7, 1351-1368.
3. Gilbert, P. E.; Martin W. R. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976, 198, 66-82.
4. Szmuszkovicz, J. U-50,488 and the κ receptor: A personalized account covering the period 1973-1990. Prog. Drug Res. 1999, 52, 168-195; and U-50,488 and the κ receptor: part II: 1991-1998. Prog. Drug Res. 1999, 53, 3-51.
5. Szmuszkovicz, J. U-50,488 and the κ receptor: A personalized account covering the period 1973-1990. Prog. Drug Res. 1999, 52, 168-195; and U-50,488 and the κ receptor: part II: 1991-1998. Prog. Drug Res. 1999, 53, 3-51.
6. Kowaluk, E. A.; Arneric S. P. Novel Molecular Approaches to Analgesia. Annu. Rep. Med. Chem. 1998, 33, 11-20.
7. Borsodi, A.; Benyhe, S.; Holzgrabe, U.; Marki, A.; Nachtsheim, C. Structurally Novel Group of Ligands Selective for KappaOpioid Receptors. Regul. Pept. 1994, 54, 27-28.
8. Kögel, B.; Christoph, T.; Friderichs, E.; Hennies, H.-H.; Matthiesen, T.; Schneider, J.; Holzgrabe, U. HZ2, a selective Kappa-opioid agonist, CNS Drug Rev. 1998, 4, 54-70.
9. Brandt, W.; Drosihn, S.; Haurand, M.;. Holzgrabe, U.; Nachtsheim C. Search for the Pharmacophore in Kappa-agonistic Diazabicyclo[3.3.1]nonan-9-one-1,5-diesters and Arylacetamides. Arch. Pharm. Pharm. Med. Chem. 1996, 329, 311-323.
10. Siener, T.; Cambareri, A.; Kuhl, U.; Englberger, W.; Haurand, M.; Kögel, B.; Holzgrabe, U. Synthesis and Opioid affinity in a Series of Opioid-type analgesics: Diazabicyclo[3.3.1]nonan-9-ones. J. Med. Chem. 2000, 43, 3746-3751.
11. Kuhl, U.; Englberger, W.; Haurand, M.; Holzgrabe, U. Diazabicyclo[3.3.1]nonanone-type Ligands for the Opioid Receptors. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 226-230.
12. Kuhl, U.; von Korff, M.; Baumann, K.; Burschka, C.; Holzgrabe, U. Stereochemical behaviour of κ-agonistic 2,4-dipyridine 3,7-diazabicyclo[3.3.1]nonanones - influence of the substituent in position N3, J. Chem. Soc., Perkin Trans. 2, 2001, 2037-2042.
13. Cambareri, A.; Zlotos, D. P.; Englberger, W.; Holzgrabe, U. Stereochemistry and opioid receptor affinity of 2,4-dipyridine 3,7-diazabicyclo[3.3.1]nonanones - influence of the substituent in position N7. J. Heterocycl. Chem. 2002, 39, 789-798.
14. Lavecchia A.; Greco G.; Novellino, E.; Vittorio, F.; Ronsisvalle, G. Modeling of κ-opioid Receptor/Agonist Interactions Using Pharmacophore-Based and Docking Simulations. J. Med. Chem. 2000, 43, 2124-2134.
15. Metzger, T. G.; Paterlini, M. G.; Portoghese, P. S.; Ferguson, D. M. Application of the Message-Address Concept of the Docking of Naltrexone and Selective Naltrexone-derived Opioid Antagonists into the Opioid Receptor Models. Neurochem. Res. 1996, 21, 1287-1294.
16. Subramanian, G.; Paterlini, M. G.; Larson, D. L.; Portoghese, P. S.; Ferguson, D. M.; Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists. J. Med. Chem. 1998, 41, 4777-4789.
17. Iadanza, M.; Höltje, M.; Ronsisvalle, G.; Höltje, H. D. k-Opioid Receptor Model in a Phospholipid Bilayer: Molecular Dynamics Simulation. J. Med. Chem. 2002, 45, 4838-4846.
18. Wan, X.-H.; Huang, X.-Q.; Zhou, D.-H.; Jiang, H.-L.; Chen, K.X.; Chi, Z.-Q. Building 3D-structural model of kappa opioid receptor and studying its interactions with dynorphin A(1-9). Acta Pharmacol. Sin. 2000, 21, 701-708.
19. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of Rhodopsin: A G Protein-Coupled Receptor. Science 2000, 289, 739-745.
20. Okada, T.; Okada, T.; Fox, B. A.; Behnke, C. A.; Stenkamp, R. E.; Palczewski, K. X-ray Diffraction Analysis of Three-Dimensional Crystals of Bovine Rhodopsin Obtained from Mixed Micelles. J. Struct. Biol. 2000, 130, 73-80.
21. Choi, G.; Landin, J.; Galan, J. F.; Birge, R. R.; Albert, A. D.; Yeagle, P. L. Structural studies of metarhodopsin II, the activated form of the G-protein coupled receptor, rhodopsin. Biochemistry 2002, 41, 7318-24.
22. Kuhl, U.; Cambareri, A.; Sauber, C.; Sörgel, F.; Euler, H.; Hartmann, R.; Kirfel, A.; Holzgrabe, U. Synthesis, X-ray analysis, and Spectroscopic Characterization of the Hemiaminal Cyclisation Product from 2,4-dipyridine Substituted 3,7-Diazabicyclo[3.3.1]nonanone 1,5-diester. J. Chem. Soc., Perkin Trans. 2 1999, 2083-2088.
23. Siener, T.; Holzgrabe, U.; Drosihn, S.; Brandt, W. Conformational and configurational behaviour of κ-agonistic 3,7-diazabicyclo[3.3.1]nonan-9-ones - synthesis, nuclear magnetic resonance studies and semiempirical PM3 calculations, J. Chem. Soc., Perkin Trans. 2 1999, 1827-1834.
24. Filizola, M.; Laakkonen, L.; Loew, G. H. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors, Protein Eng. 1999, 12, 927-42.
25. Valiquette, M.; Vu, H. K.; Yue, S. Y.; Wahlestedt, C.; Walker, P. Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands, J. Biol. Chem. 1996, 271, 18789-18796.
26. Zhang, L.; DeHaven, R. N.; Goodman, M. NMR and modeling studies of a synthetic extracellular loop II of the kappa opioid receptor in a DPC micelle. Biochemistry 2002, 41, 61-68.
27. Meng, F.; Hoversten, M. T.; Thompson, R. C.; Taylor, L.; Watson, S. J.; Akil, H.; A chimeric study of the molecular basis of affinity and selectivity of the kappa and the delta opioid receptors. Potential role of extracellular domains. J. Biol. Chem. 1995, 270, 12730-6.
28. March, J. Advanced Organic Chemistry - Reaction, Mechanism, and Structure, 3rd ed.; J. Wiley: New York, 1985.
29. Blundell, T. L.; Sibanda, B. L.; Sternberg, M. J. E.; Thornton, J. M. Knowledge-based prediction of protein structures and the design of novel molecules. Nature 1987, 326, 347-352.
30. Blundell, T. L.; Carney, D.; Gardner, S.; Hayes, F.; Howlin, B.; Hubbard, T.; Overington, J.; Singh, D. A.; Sibanda, B. L.; Sutcliffe, M. Knowledge-based protein modelling and design. Eur. J. Biochem. 1988, 172, 513-520.
31. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghi, C.; Alagona, G.; Profeta, S.; Weiner, P. A new Force Field for molecular mechanical simulation of nucleic acids and proteins, J. Am. Chem. Soc., 1984, 106, 765-784.
32. http://www.gpcr.org/7tm/seq/vis/OPRK_HUMAN/OPRK_HUMAN.html.
33. Laskowski, R. A.; MacArthur, M. W.; Moss, D. S.; Thornton, J. M.; PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283-91.
34. Jones, G.; Willett, P.; Glen, R. C. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 1995, 245, 43-53.
35. Jones, G., Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748.
36. Gaussian 98 (Revision A.1x), Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, Jr., J. A.; Stratmann, R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Salvador, P.; Dannenberg, J. J.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.; Gonzalez, C.; Head-Gordon, M.; Replogle, E. S.; Pople, J. A. Gaussian, Inc., Pittsburgh, PA, 2001.
37. Yasuda, M. Dissociation Constants of Some Carboxylic Acids in Mixed Aqueous Solvents. Bull. Chem. Soc. Jpn. 1959, 32, 429-432.